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Abstract 
The drug discovery research of clinical-use antioxidants, which may control various vascular 
disorders caused by the oxidative stress, is extremely important.  We present the development of an 
in vivo evaluation system of antioxidants for their vascular protective activities using the chick 
embryonic chorioallantoic membrane (CAM).  In the case of 12-days chick embryos, the topical 
administration of 2,2'-azobis(2-methylpropionamidine) dihydrochloride (AAPH) induced their 
vascular injuries against the CAM veins and venous capillaries but without substantial fatal damage.  
Artepillin C, a potent natural antioxidant, did not show the chick embryo’s venous injury, and 
pre-treatment with artepillin C would tend to protect the CAM veins injuries induced by the 
post-administration of AAPH.  These results suggest that artepillin C might be able to protect the 
AAPH-induced vascular injury in in vivo.  In conclusion, we showed the possibility of in vivo 
evaluation system of antioxidants for their vascular protective activities using the chick embryo.   
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1. Introduction 
     Agents with anti-inflammatory and antioxidant 
actions have been demonstrated to exert beneficial 
effects on cardiovascular diseases (1).  In fact, the in 
vitro evaluation system of antioxidants is being 
mainly used now.  It, however, has a problem of no 
appreciable in vivo redox status of the antioxidants. 
 Preclinical assays generally using mammalian 
models such as mouse and rat are time-consuming, 
expensive, and require special facilities and limitation 
from ethical and legal points of view.  Therefore, the 
developments of an alternative method of the 
mammalian models are necessary.   
     The chick embryo is frequently used as an 
alternative experimental animal for angiogenic 
investigations (2).  Current laws regulating animal 
experimentation in Japan allows us to use chick 
embryo without authorization from our animal 
experimentation committee.  The development of an 
in vivo model using the chick embryo has more 
advantages, such as, handy-size, quickness, less 
expensiveness, and possible building in 
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high-throughput screening than a general animal 
model.   
     We adopted artepillin C as an antioxidant to 
evaluate the utility of our designed in vivo model 
using the chick embryo.  Artepillin C is a 
diprenyl-p-hydroxycinnamic acid first isolated from 
Baccharis species as a major constituent (>5%) in 
Brazilian propolis (3).  Artepillin C showed a potent 
antioxidative activity for lipid peroxidation (4).  We 
succeeded in the first total synthesis of artepillin C (5), 
and then we termed “isoprenomics” for medicinal 
chemistry of isoprenoids involved in their structural 
analyses, biosyntheses, biological functions, and 
chemotypes (6).   
     In this paper, we present the development of an 
in vivo evaluation system of antioxidants for their 
vascular protective activities using the chick embryo.   
 
2. Materials and Methods 
 
2.1. In vivo model for the evaluation of 
antioxidants using the 6- or 12-days chick embryo 
     Fertilized chicken eggs were purchased from 
Goto Hatchery, Inc. (Gifu, Japan).  The pro- or 
anti-oxidative effects of AAPH and artepillin C on the 
chick embryonic chorioallantoic membrane (CAM) 
vascular were evaluated according to the CAM 
method (7).  CAM vascular injury was judged by ratio 
to total number of egg of inhibited one; digestion 
(Figure 1B) or disappearance (Figure 1C) of CAM 
blood vessel within the silicon ring.  Figure 1A 
shows the control (no injury).   
     Fertilized chicken eggs (Ishii co-ltd, Inc., 
Tokushima, Japan) were incubated in a humidified 
incubator at 37.6 °C for 9 days.  At day 10, air cell 
region and a part of the CAM blood vessel region (2 x 
2 cm) on the egg shell were cut off with a grinder.  A 
shell membrane was peeled off from CAM and the 
shell membrane was removed.  Opened shell window 
was sealed with opsite and then the egg was incubated 
at 37.6°C in a humidified atmosphere until day 12.  
At day 12, a silicon ring was placed on the CAM 
blood vessel and various concentrations of antioxidant 
solution including 1% methyl cellulose/0.9% NaCl 
(5% DMSO) were dropped into the silicon ring.  
Opened shell window was sealed again with tegaderm 
and the egg was incubated at 37.6°C in a humidified 
atmosphere for 24 hours.  CAM veins (size: ca. 0.5 
mm) and venous capillaries (size: < 0.1 mm) injury 
were judged by according to the above-mentioned 
method.  The significance of difference between 
different groups was analyzed by the multiple 
numbers of eggs.   
 
2.2. Protection effect of artepillin C for 
AAPH-induced oxidative vascular injury 
     At day 12, a silicon ring was placed on the 
CAM blood vessel, and various concentrations of 
artepillin C including 1% methyl cellulose/0.9% NaCl 
(5% DMSO) were dropped into the silicon ring.  
Opened shell window was sealed again with tegaderm 
and the egg was incubated at 37.6°C in a humidified 
atmosphere for 1 hour.  The topical administration of 
AAPH (3 mg) into the silicon ring and egg was 
incubated at 37.6°C in a humidified atmosphere for 24 
hours.  CAM veins and venous capillaries injury 
were judged according to the description of 2.1.   
 
3. Results 
 
3.1. CAM vascular toxicity of AAPH or artepillin 
C for 6- and 12-days chick embryo 
     The topical administration of AAPH (a dose 
from 100 to 300 g), a water-soluble prooxidant, to 
the CAM of 6-days chick embryos, resulted in their 
vascular injuries of percentages from 0 to 100%  
dose dependently, which were correlated with their 
increased fatal rate of percentages from 0 to 71% 
(Table 1).  Artepillin C (a dose from 0.1 to 10 g), a 
potent natural antioxidant, tends to show a weak 
vascular injury and fatal damage (each 33% at 1.0 g) 
(Table 2).   
     In the case of 12-days chick embryos, AAPH 
(doses from 0.3 to 7.0 mg) induced their vascular 
injuries up to 80% against the CAM veins and venous 
capillaries without substantial fatal damage (Table 3).  
Artepillin C, with its dose of up to 30 g, did not 
show the CAM veins injury and fatality of chick 
embryo (Table 4).   
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3.2. Protection effect of artepillin C for 
AAPH-induced oxidative vascular injury 
     In the case of 12-days chick embryos, 
pre-treatment with artepillin C (a dose of 1 and 10 g) 
tends to protect the CAM veins injuries, and the injury 
rate has de-creased up to 20%, induced by the 
post-administration of 3 mg of AAPH (Table 5).   
 
 
Figure 1. CAM images of no injury (A), digestion (B), and disappearance (C) of CAM blood vessel 
 
Table 1. Embryo (6-days) and CAM vascular toxicity of AAPH 
AAPH (g) CAM vascular injury rate (%) Embryo fatal rate (%) Number of eggs 
  0  14 14 7 
100   0  0 5 
150  33 11 9 
200  86 43 7 
250  86 71 7 
300 100 71 7 
 
Table 2. Embryo (6-days) and CAM vascular toxicity of artepillin C 
Artepillin C (g) CAM vascular injury rate (%) Embryo fatal rate (%) Number of eggs 
 0  0  0 7 
   0.1 17  0 6 
   1.0 33 33 6 
10 17  0 6 
 
Table 3. Embryo (12-days) and CAM vascular toxicity of AAPH 
AAPH 
(mg) 
Veins injury rate 
(%) 
Venous capillary injury rate 
(%) 
Embryo fatal rate 
(%) 
Number of eggs 
 0  0 20  0 5 
0.3  0 20 20 5 
1.0  0 20  0 5 
3.0 40 60  0 5 
7.0 80 80  0 5 
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Table 4. Embryo (12-days) and CAM vascular toxicity of artepillin C 
Artepillin C 
(g) 
Veins injury rate 
(%) 
Venous capillary injury rate 
(%) 
Embryo fatal rate 
(%) 
Number of eggs 
 0  0  0 0 5 
   0.1 20 60 0 5 
   1.0  0 20 0 5 
10  0 25 0 4 
30  0  0 0 2 
 
Table 5. Protection effect of artepillin C for AAPH-induced vascular injury 
Artepillin C 
(g) 
AAPH 
(mg) 
Veins injury rate 
(%) 
Venous capillary injury 
 rate (%) 
Embryo fatal rate 
(%) 
Number of 
eggs 
 0 0  0  20  0 5 
 0 3 80 100 40 5 
   0.1 3 40 100  0 5 
 1 3 20  80  0 5 
10 3 20  60  0 5 
 
4. Discussion 
     In this paper, we presented the development of 
the new in vivo evaluation system of antioxidants for 
their vascular protective activities using the chick 
embryo.  In the case of 6-days chick embryo, not 
only AAPH but also artepillin C showed the CAM 
vascular injury and embryo’s fatality.  These results 
suggest that immature developing CAM vasculature 
might have low tolerance to oxidative injury. Besides, 
artepillin C did not show the CAM veins injury 
without their fatal damage while AAPH had shown 
vascular injuries as observed in the case of 12-days 
chick embryo.  The CAM blood vessels of chick 
embryo formed during the day 4 or 5 and its rapid 
capillary proliferation continued until day 11 (8), 
therefore we thought that this different result depends 
on the maturity of the CAM blood vessels.  We 
presumed that artepillin C would tend to protect the 
CAM veins injuries induced by AAPH because of the 
amphiphilic property of artepillin C having both 
vascular penetrativeness and still water solubility.  
Our developed in vivo evaluation system of 
antioxidants for their vascular protective activities 
using the chick embryo might be useful for the drug 
discovery research of clinical-use antioxidants.   
 
5. Conclusion 
     In our developed in vivo evaluation system of 
antioxidants for their vascular protective activities 
using the chick embryo, we demonstrated that 
artepillin C would tend to protect the AAPH-induced 
vascular injury of 12-days chick embryonic CAM.   
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